Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
| Conditions: | Mesothelioma|Pleural Mesothelioma |
| Start Date: | January 1, 2009 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00895648 |
| Study Type: | Interventional |
| Intervention: | Drug: Pemetrexed|Drug: Cisplatin |
| Study Design: | Control: Uncontrolled|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University Health Network, Toronto|Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 45 |
| Funded By: | Other|Industry |
| First Received: | May 6, 2009 |
| End Date: | January 1, 2020 |
| Last Updated: | March 8, 2010 |
| Last Verified: | March 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
